Apolipoprotein B in cardiovascular risk assessment
M Ahmad, AD Sniderman, RA Hegele - CMAJ, 2023 - Can Med Assoc
2. Linton MRF, Yancey PG, Davies SS, et al. The role of lipids and lipoproteins in
atherosclerosis [updated 2019 Jan. 3]. In: Feingold KR, Anawalt B, Blackman MR, et al …
atherosclerosis [updated 2019 Jan. 3]. In: Feingold KR, Anawalt B, Blackman MR, et al …
Apolipoprotein B versus non-high-density lipoprotein cholesterol: is the debate really over?
V Bittner - European Journal of Preventive Cardiology, 2022 - academic.oup.com
Apolipoprotein B (apoB)-containing lipoproteins are causal in atherosclerosis. 1
Measurement of low-density lipoprotein cholesterol (LDL-C) only (without taking into …
Measurement of low-density lipoprotein cholesterol (LDL-C) only (without taking into …
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
JH Contois, JP McConnell, AA Sethi, G Csako… - 2009 - academic.oup.com
Background: Low-density lipoprotein cholesterol (LDL-C) has been the cornerstone
measurement for assessing cardiovascular risk for nearly 20 years. Content: Recent data …
measurement for assessing cardiovascular risk for nearly 20 years. Content: Recent data …
Apolipoprotein B measurement: Need for standardization
JH Contois, V Delatour - Journal of Clinical Lipidology, 2018 - lipidjournal.com
Apolipoprotein B (apo B) is a component of all atherogenic lipoproteins [chylomicrons, very
low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), low density …
low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), low density …
Apolipoprotein B vs low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol as the primary measure of apolipoprotein B lipoprotein-related …
AD Sniderman, AM Navar, G Thanassoulis - JAMA cardiology, 2022 - jamanetwork.com
In 1979, Avogaro et al1 reported that apolipoprotein B (apoB) was a more accurate marker
of the risk of a myocardial infarction than total cholesterol. In 1980, Sniderman et al2 …
of the risk of a myocardial infarction than total cholesterol. In 1980, Sniderman et al2 …
Coronary heart disease prediction: Apolipoprotein B shows its might again–but still in vain?
PT Kovanen, M Jauhiainen - European journal of preventive …, 2015 - journals.sagepub.com
Plasma concentration of apolipoprotein B (apoB) reflects the number of the entire spectrum
of atherogenic lipoprotein particles in the circulation. Since apoB reliably detects the total …
of atherogenic lipoprotein particles in the circulation. Since apoB reliably detects the total …
Apolipoprotein B/A1 and risk of cardiovascular disease
L Lind - The Lancet, 2008 - thelancet.com
Comment 186 www. thelancet. com Vol 372 July 19, 2008 flicting. Some showed a
superiority of the apolipoprotein B/A1 over conventional lipid measurements or that …
superiority of the apolipoprotein B/A1 over conventional lipid measurements or that …
A translational tool to facilitate use of apolipoprotein B for clinical decision-making
J Cole, JD Otvos, AT Remaley - Clinical Chemistry, 2023 - academic.oup.com
Background Despite recent large-scale discordance studies showing definitively that
atherosclerotic cardiovascular disease (ASCVD) risk correlates better with apolipoprotein B …
atherosclerotic cardiovascular disease (ASCVD) risk correlates better with apolipoprotein B …
Physiological bases for the superiority of apolipoprotein b over low‐density lipoprotein cholesterol and non–high‐density lipoprotein cholesterol as a marker of …
T Glavinovic, G Thanassoulis, J de Graaf… - Journal of the …, 2022 - Am Heart Assoc
In 2019, the European Society of Cardiology/European Atherosclerosis Society stated that
apolipoprotein B (apoB) was a more accurate marker of cardiovascular risk than low‐density …
apolipoprotein B (apoB) was a more accurate marker of cardiovascular risk than low‐density …
[HTML][HTML] Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial
AD Sniderman, J Bergeron, J Frohlich - CMAJ, 2001 - Can Med Assoc
The Quebec Cardiovascular Study is the most up-to-date, prospective, epidemiologic
investigation of the risk factors responsible for coronary artery disease. It is also the first …
investigation of the risk factors responsible for coronary artery disease. It is also the first …
